We are live on ! Find out more
RI

RTW Investments Portfolio holdings

AUM $10B
1-Year Est. Return 135.35%
This Fund
S&P 500
This Quarter Est. Return
+23.77%
1 Year Est. Return
+135.35%
3 Year Est. Return
+383.62%
5 Year Est. Return
+523.94%
10 Year Est. Return
+15,981.64%
AUM
$4.34B
AUM Growth
+$467M
Cap. Flow
-$99.7M
Cap. Flow %
-2.3%
Top 10 Hldgs %
48.91%
Holding
111
New
4
Increased
17
Reduced
21
Closed
25

Top Buys

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$50.7M
2
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$47.6M
3
PTCT icon
PTC Therapeutics
PTCT
+$28.2M
4
IMCR icon
Immunocore
IMCR
+$21.7M
5
AXSM icon
Axsome Therapeutics
AXSM
+$13.2M

Top Sells

Rank Stock Value
1
TNDM icon
Tandem Diabetes Care
TNDM
+$32.9M
2
QTRX icon
Quanterix
QTRX
+$29.5M
3
VERU icon
Veru
VERU
+$25.1M
4
GMED icon
Globus Medical
GMED
+$22.5M
5
AXNX
Axonics, Inc. Common Stock
AXNX
+$20.3M

Sector Composition

Rank Sector Weight
1 Healthcare 99.21%
2 Financials 0.67%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VERU icon
101
Veru
VERU
$37.4M
– –
-222,098
Closed -$25.1M
TBIO
102
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
– –
-5,556
Closed -$180K
OMIC
103
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
– –
-3,333
Closed -$382K
SLGC
104
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
– –
-2,114,830
Closed -$9.56M
PNT
105
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
– –
-490,000
Closed -$3.34M
GTH
106
DELISTED
Genetron Holdings Limited ADS
GTH
– –
-399,654
Closed -$2.04M
UTRS
107
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
– –
-8,300
Closed -$390K
APEN
108
DELISTED
Apollo Endosurgery, Inc.
APEN
– –
-258,064
Closed -$942K
ISO
109
DELISTED
IsoPlexis Corporation Common Stock
ISO
– –
-365,000
Closed -$788K
CTIC
110
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
– –
-471,630
Closed -$2.82M
LJPC
111
DELISTED
La Jolla Pharmaceutical Company
LJPC
– –
-2,327,403
Closed -$7.42M
1 2 3 4
5

Similar funds

HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
IIM
INTECH Investment Management West Palm Beach, Florida $10.2B AUM 28.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

RTW Investments's Q3 2022 Portfolio in Review

As of Q3 2022, RTW Investments held 111 positions worth $4.34B, up 12% from $3.87B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

RTW Investments's Q3 2022 filing shows 4 new, 17 increased, 21 reduced and 25 closed positions. Its largest new stake was IVERIC bio, Inc. Common Stock: 3,625,000 shares worth $65M. The largest sale was Tandem Diabetes Care, an estimated $32.9M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier, followed by Financials and Industrials.

  • RTW Investments's largest Q3 2022 buy was IVERIC bio, Inc. Common Stock: 3,625,000 shares worth $65M.
  • RTW Investments added most to Ultragenyx Pharmaceutical in Q3 2022, an estimated $50.7M increase.
  • RTW Investments's biggest Q3 2022 reduction was Tandem Diabetes Care, cutting an estimated $32.9M.
  • RTW Investments fully exited Quanterix in Q3 2022, selling an estimated $29.5M.
  • RTW Investments's ten largest holdings make up 49% of its $4.34B portfolio in Q3 2022.
  • RTW Investments opened 4 new positions and closed 25 in Q3 2022.
  • RTW Investments's portfolio value rose 12% quarter-over-quarter to $4.34B.

Based on RTW Investments's 13F filing for Q3 2022, filed 14 Nov 2022.